Auracast-ready Starkey recognised on 2026 Inc Power Partner B2B list

US-based hearing technology manufacturer Starkey has been named an Inc Power Partner for 2026 – the second year running it has received the B2B honour. The recognition comes as the firm accelerates its rollout of next-generation connectivity, including the recently launched Omega AI+ , which features Auracast as standard....

Continue reading at Aurahear

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change — this is a business award announcement with no clinical evidence or practice guidance.

✦ Why It Matters ✦

Starkey's repeat recognition and simultaneous product rollout signal continued investment in Auracast Bluetooth connectivity, which could eventually expand hearing loop and audio-sharing options for patients in public venues.

✦ Key Points ✦

01Starkey named a 2026 Inc. Power Partner for the second consecutive year.
02Recognition coincides with rollout of Auracast-ready hearing aids, a new Bluetooth broadcast audio standard.
03New Omega hearing aid line launched alongside the award announcement.
04The Inc. Power Partner list recognises B2B companies rated highly by their clients.
05Article is hosted on aurahear.com, a Starkey-affiliated domain, indicating promotional framing.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Starkey has been named a 2026 Inc. Power Partner for the second consecutive year.

press releasesupported

Starkey is rolling out Auracast-ready connectivity across its hearing aid portfolio.

press releaseunclear

Starkey has launched a new hearing aid line called Omega.

press releasesupported

✦ Related stories ✦

PubMed·Clinical trial·Hearing aids·8w ago

Unilateral and Bilateral Hearing Aids for Age-Related Hearing Loss: A Randomized Clinical Trial

of this RCT directly bear on bilateral vs. unilateral fitting decisions for adults with symmetrical mild-to-moderate age-related hearing loss; full-text review is essential, but this is potentially practice-changing depending on the direction and magnitude of the findings.

PubMed·Journal article·Hearing aids·8w ago

Hearing aids for mild to moderate hearing loss in adults

Audiologists should monitor this updated Cochrane review's conclusions closely; if it confirms benefit, it strengthens the case for fitting hearing aids in mild-loss patients who are currently under-served.

PubMed·Journal article·Hearing aids·3mo ago

Digital Interventions for First-Time Hearing Aid Users: A Systematic Review and Meta-Analysis of Efficacy and Effectiveness

Clinicians should consider incorporating evidence-based digital support tools (apps, online programmes) into onboarding protocols for first-time hearing aid users, pending the meta-analysis's specific effect-size findings.

PubMed·Journal article·Hearing aids·4w ago

Self-Fitting Versus Professional-Fitting Hearing Aids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

The meta-analytic findings on self-fitting vs. professional-fitting outcomes should prompt audiologists to review their value proposition and counsel patients on where professional fitting adds measurable benefit, particularly for complex hearing profiles.

PubMed·Journal article·Hearing aids·4mo ago

Individuals with near-normal audiograms but perceived hearing difficulties can achieve aided outcomes on par with those of peers with mild hearing loss

Audiologists should consider fitting hearing aids for patients with near-normal audiograms who report significant hearing difficulty, as aided outcomes can match those of patients with confirmed mild hearing loss.

PubMed·Journal article·Hearing aids·3mo ago

The effect of treating hearing loss with hearing aids on plasma biomarkers of Alzheimer's disease and related dementias

If the study shows hearing-aid use reduces Alzheimer's-related plasma biomarkers, it would strengthen the case for early hearing rehabilitation as a potential dementia-prevention strategy, though findings should be weighed by sample size and study design before changing practice.

PubMed·Journal article·Hearing aids·5mo ago

Hearing Aid Efficacy-Timely Trial Finds Professional Guidance Trumps Costly Tech

This trial supports prioritising high-quality audiological fitting and counselling over premium hearing aid technology alone — audiologists should emphasise their professional value proposition when discussing device options with patients.